Phase II Neoadjuvant in Inflammatory Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Lapatinib|DRUG: Paclitaxel|DRUG: 5-Fluorouracil (5-FU)|DRUG: Epirubicin|DRUG: Cyclophosphamide
Sponsor: M.D. Anderson Cancer Center
Collaborators: GlaxoSmithKline